Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Celularity, Lowers Price Target to $5

Morgan Stanley analyst Jeffrey Hung maintains Celularity (NASDAQ:CELU) with a Equal-Weight and lowers the price target from $8 to $5.
byBenzinga Newsdesk
September 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Jeffrey Hung maintains Celularity (NASDAQ:CELU) with a Equal-Weight and lowers the price target from $8 to $5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0